Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

93427

registered interest
date	14/10/2014
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Immigration: West Africa
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what steps are being taken to reduce the immigration restrictions on doctors from West Africa who currently work in the United Kingdom and who volunteer to return to West Africa temporarily to provide medical support for those suffering from ebola.
tabling member printed	The Countess of Mar
uin	HL2093
answer	answer is ministerial correction date of answer 21/10/2014 answer text <p>The Immigration Rules already provide for doctors here under the Tier 2 skilled work route and working for the UK health system to return to their home countries for short periods to provide support. The Tier 2 rules allow for periods of unpaid leave of up to one month in every 12 month period. There is also nothing in the Immigration Rules to prevent someone on a Tier 2 visa using their annual leave to volunteer in Africa.</p><p> </p> answering member printed Lord Bates question first answered 21/10/2014 16:30:37 answering member 1091 label Biography information for Lord Bates
tabling member	1861 label Biography information for The Countess of Mar

93428

registered interest
date	14/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Aspartame
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government when they intend to publish the results of the Hull trial on aspartame on the Food Standards Agency website.
tabling member printed	The Countess of Mar
uin	HL2094
answer	answer is ministerial correction date of answer 24/10/2014 answer text <p>The Food Standards Agency (FSA) advise that the paper is still in the peer-review process. Publication in a scientific journal is expected and is the preferable route as it makes the data more readily available to the scientific community. Once this happens the FSA will publish the final report on foodbase, the FSA’s open access repository.</p><p> </p> answering member printed Earl Howe question first answered 24/10/2014 11:26:46 answering member 2000 label Biography information for Earl Howe
tabling member	1861 label Biography information for The Countess of Mar

79197

registered interest
date	21/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Lyme Disease
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 25 June 2012 (WA 21–2), whether they consider that the use of the CE-marked Trinity Biotech EU Lyme western blot test, when used with cerebrospinal fluid, would constitute "use of an in-house test" as defined by the Medical and Healthcare Products Regulatory Agency guidance.
tabling member printed	The Countess of Mar
uin	HL1358
answer	answer is ministerial correction date of answer 29/07/2014 answer text <p>Use of a sample type not indicated by the manufacturer would be considered to be off label use of the device. This off label use is not regulated by the Medicines and Healthcare products Regulatory Agency and would be the responsibility of the laboratory.</p> answering member printed Earl Howe question first answered 29/07/2014 13:16:10 answering member 2000 label Biography information for Earl Howe
tabling member	1861 label Biography information for The Countess of Mar

78303

registered interest
date	16/07/2014
answering body	Department for Business, Innovation and Skills
answering dept id	26
answering dept short name	Business, Innovation and Skills
answering dept sort name	Business, Innovation and Skills
hansard heading	Aspartame
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how many kilograms of aspartame were imported into the United Kingdom in each year from 2000 to 2013 inclusive.
tabling member printed	The Countess of Mar
uin	HL1193
answer	answer is ministerial correction date of answer 22/07/2014 answer text <table><tbody><tr><td colspan="5"><p>Data showing the volume (kilograms) of UK imports of aspartame during 2000-2013 is given in Table 1 below. The figures are sourced from HMRC’s Overseas Trade Statistics database.</p><p><strong>Table 1: UK imports of aspartame (HS code 21069092)</strong></p></td><td> </td></tr><tr><td><strong> </strong></td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Year</td><td>Net mass (kgs)</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>2013</td><td>76,393,895</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>2012</td><td>85,600,024</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>2011</td><td>63,298,987</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>2010</td><td>54,483,436</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>2009</td><td>51,466,542</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>2008</td><td>58,734,046</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>2007</td><td>50,538,317</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>2006</td><td>59,274,993</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>2005</td><td>56,112,033</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>2004</td><td>63,320,625</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>2003</td><td>61,259,916</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>2002</td><td>43,939,777</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>2001</td><td>40,554,490</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>2000</td><td>29,438,869</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td colspan="4">Source: HMRC Overseas Trade Statistics database</td><td> </td><td> </td></tr><tr><td colspan="6">Note: HS 21069092 = Food preparations, n.e.s., not containing milkfats,</td></tr><tr><td colspan="6">sucrose, isoglucose starch or glucose or containing, by weight, &lt; 1,5% milkfat,</td></tr><tr><td colspan="5">&lt; 5% sucrose or isoglucose, &lt; 5% glucose or &lt; 5% starch&quot; only.</td><td> </td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr></tbody></table> answering member printed Lord Livingston of Parkhead question first answered 22/07/2014 16:58:32 answering member 4278 label Biography information for Lord Livingston of Parkhead
tabling member	1861 label Biography information for The Countess of Mar

78304

registered interest
date	16/07/2014
answering body	Cabinet Office
answering dept id	53
answering dept short name	Cabinet Office
answering dept sort name	Cabinet Office
hansard heading	Alzheimer's Disease
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how many deaths in the United Kingdom were attributed to Alzheimer’s disease in 1970, 1982 and 2013.
tabling member printed	The Countess of Mar
uin	HL1194
answer	answer is ministerial correction date of answer 21/07/2014 answer text <p>The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.</p><p> </p> answering member printed Lord Wallace of Saltaire question first answered 21/07/2014 14:28:33 answering member 1816 label Biography information for Lord Wallace of Saltaire attachment 1 file name PQ HL1194 ONS 323.pdf title ONS Letter to PEER
tabling member	1861 label Biography information for The Countess of Mar

77264

registered interest
date	10/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Lyme Disease
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government when the testing of the cerebrospinal fluid of patients suspected of having Lyme disease using the Trinity Biotech kit at the Health Protection Agency’s Lyme Borreliosis Unit began; how many patients' samples were tested in that way; and how many patients were recorded as being positive over that period of time.
tabling member printed	The Countess of Mar
uin	HL998
answer	answer is ministerial correction date of answer 24/07/2014 answer text <p>The Trinity Biotech blot has been in use since 2007 by the former Health Protection Agency's Lyme Borreliosis Unit for testing cerebrospinal fluid (CSF) and proved very reliable. It has also been used in this way by other laboratories in Europe. However, CSF antibodies will not be present if there is no evidence of any other antibodies in the serum. Data is not collected centrally on specific samples from patients as the final diagnosis is made by the clinician on the basis of the test results and the clinical presentation.</p> answering member printed Earl Howe question first answered 24/07/2014 12:31:17 answering member 2000 label Biography information for Earl Howe
tabling member	1861 label Biography information for The Countess of Mar

77265

registered interest
date	10/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Lyme Disease
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether, in December 2011, the Clinical Pathology Accreditation Service was made aware of modifications by the Health Protection Agency’s Lyme Borreliosis Unit to the Trinity Biotech immunoblot kit to be used for testing human cerebrospinal fluid.
tabling member printed	The Countess of Mar
uin	HL999
answer	answer is ministerial correction date of answer 24/07/2014 answer text <p>The former Health Protection Agency's Lyme Borreliosis Unit (HPA LBU) was accredited by Clinical Pathology Accreditation who had access to, and was able to review, all the standard operating procedures of the unit.</p><p> </p><p>The Trinity Biotech Lyme Western Blot is a qualitative in vitro assay for the detection of Immunoglobulin (IgG or IgM) antibodies in human samples against specific antigens/proteins of <em>Borrelia afzelii, Borrelia garinii and Borrelia burgdorferi</em>. The Trinity Biotech Lyme Western Blot is intended as a confirmatory assay for use in testing human samples which have been previously found to be positive or equivocal using an Enzyme Immunoassay and Immunofluroescent Assay or other appropriate screening method. Positive second-tier results are supportive evidence of infection with <em>B. burgdorferi</em>. The diagnosis of Lyme disease should be made based on history and symptoms (such as erythema migrans), and other laboratory data, in addition to the presence of antibodies to <em>B. burgdorferi</em>. The Trinity Biotech blot has been in use since 2007 by the former HPA’s LBU for testing cerebrospinal fluid (CSF) and proved very reliable. This technique has also been in use widely across Europe during this period as a diagnostic test using CSF as a sample to support the diagnosis of neuroborreliosis.</p> answering member printed Earl Howe question first answered 24/07/2014 12:32:59 answering member 2000 label Biography information for Earl Howe
tabling member	1861 label Biography information for The Countess of Mar

77266

registered interest
date	10/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Lyme Disease
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what evidence existed to show that the Health Protection Agency’s Lyme Borreliosis Unit (LBU) conformed with European Union and United Kingdom legislation for the use of the Trinity Biotech kit for <i>in vitro</i> testing when used with cerebrospinal fluid; and what testing was carried out by the LBU to verify that the use of that test kit was suitable, and sufficiently sensitive, for the detection of European and United Kingdom species of Borrelia infections in cerebrospinal fluid.
tabling member printed	The Countess of Mar
uin	HL1000
answer	answer is ministerial correction date of answer 24/07/2014 answer text <p>The former Health Protection Agency's Lyme Borreliosis Unit adhered to legislation related to diagnostic testing. The Trinity Biotech Lyme Western Blot technique was widely used in Europe at that time for serum and samples. Controls were run with each batch of the test to verify the tests accuracy and sensitivity. Quality assurance samples were run to ensure independent validation of the results.</p> answering member printed Earl Howe question first answered 24/07/2014 14:21:30 answering member 2000 label Biography information for Earl Howe
tabling member	1861 label Biography information for The Countess of Mar

77267

registered interest
date	10/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Lyme Disease
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether the Health Protection Agency’s Lyme Borreliosis Unit adhered to the Health Protection Agency's published guidelines on <i>Commercial and In-House Diagnostic Tests: Evaluations and Validations</i> in carrying out testing of cerebrospinal fluid of patients suspected of having Lyme disease using the Trinity Biotech kit.
tabling member printed	The Countess of Mar
uin	HL1001
answer	answer is ministerial correction date of answer 24/07/2014 answer text <p>The former Health Protection Agency's (HPA) Lyme Borreliosis Unit adhered to the HPA’s published guidelines on Commercial and In-House Diagnostic Tests.</p> answering member printed Earl Howe question first answered 24/07/2014 13:24:08 answering member 2000 label Biography information for Earl Howe
tabling member	1861 label Biography information for The Countess of Mar

77268

registered interest
date	10/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Lyme Disease
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether the Health Protection Agency's Lyme Borreliosis Unit informed clinicians and patients of test results on cerebrospinal fluid in accordance with Medicines and Healthcare Products Regulatory Agency guidance in carrying out testing of cerebrospinal fluid of patients suspected of having Lyme disease using the Trinity Biotech kit.
tabling member printed	The Countess of Mar
uin	HL1002
answer	answer is ministerial correction date of answer 24/07/2014 answer text <p>The former Health Protection Agency's Lyme Borreliosis Unit (HPA LBU) informed requesting clinicians but not patients of the results on cerebrospinal fluid (CSF) and also provided a clinical interpretive service to the requesting clinician. Referring laboratories and clinicians managing patients with Lyme disease were aware of the limitations of diagnostic tests for serum and CSF through publications and educational meetings. It is the role of the requesting clinician to be guided by the interpretation of the laboratory result and to use these results in the light of the clinical presentation to make a diagnosis and a management plan for individual patients. It is also important to note that the former HPA’s LBU performed diagnostic tests on samples referred by other laboratories</p> answering member printed Earl Howe question first answered 24/07/2014 13:33:24 answering member 2000 label Biography information for Earl Howe
tabling member	1861 label Biography information for The Countess of Mar